Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 45,890 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002060 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,890 Underlying: Common Stock · 45,890 shares Expires 2033-02-13 F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 5,765 | $162.01 | $933,987.65 |
DisclosureSEC source: 0001225208-23-002060 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,696.0055 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantCommon Stock | 12,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002060 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,461.0055 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Hait WilliamSee Remarks
|
GrantRestricted Share Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002061 · doc4.xml · derivative · entry 4 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Hait WilliamSee Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 41,366 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002061 · doc4.xml · derivative · entry 3 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,366 Underlying: Common Stock · 41,366 shares Expires 2033-02-13 F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Hait WilliamSee Remarks
|
Tax withholdingCommon Stock | 4,586 | $162.01 | $742,977.86 |
DisclosureSEC source: 0001225208-23-002061 · doc4.xml · nonDerivative · entry 2 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,747 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
Hait WilliamSee Remarks
|
GrantCommon Stock | 9,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002061 · doc4.xml · nonDerivative · entry 1 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,333 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
GrantRestricted Share Units · Derivative | 3,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002062 · doc4.xml · derivative · entry 6 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,704 Underlying: Common Stock · 3,704 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F6 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 61,295 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002062 · doc4.xml · derivative · entry 5 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,295 Underlying: Common Stock · 61,295 shares Expires 2033-02-13 F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 7,158 | $162.01 | $1,159,667.58 |
DisclosureSEC source: 0001225208-23-002062 · doc4.xml · nonDerivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,824.9545 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:24 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
GrantCommon Stock | 17,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002062 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,982.9545 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
GrantRestricted Share Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 3,417 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 56,555 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,555 Underlying: Common Stock · 56,555 shares Expires 2033-02-13 F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
Tax withholdingCommon Stock | 6,430 | $162.01 | $1,041,724.30 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,915.2661 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
GrantCommon Stock | 13,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,345.2661 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Swanson James D.See Remarks
|
GrantRestricted Share Units · Derivative | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002064 · doc4.xml · derivative · entry 4 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341 Underlying: Common Stock · 1,341 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Swanson James D.See Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 22,191 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002064 · doc4.xml · derivative · entry 3 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,191 Underlying: Common Stock · 22,191 shares Expires 2033-02-13 F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Swanson James D.See Remarks
|
Tax withholdingCommon Stock | 918 | $162.01 | $148,725.18 |
DisclosureSEC source: 0001225208-23-002064 · doc4.xml · nonDerivative · entry 2 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,277 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Swanson James D.See Remarks
|
GrantCommon Stock | 3,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002064 · doc4.xml · nonDerivative · entry 1 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,195 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantRestricted Share Units · Derivative | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002065 · doc4.xml · derivative · entry 4 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,906 Underlying: Common Stock · 3,906 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 64,634 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002065 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,634 Underlying: Common Stock · 64,634 shares Expires 2033-02-13 F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 10,569 | $162.01 | $1,712,283.69 |
DisclosureSEC source: 0001225208-23-002065 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,590.001 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantCommon Stock | 21,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002065 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,159.001 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
GrantRestricted Share Units · Derivative | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002066 · doc4.xml · derivative · entry 6 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,953 Underlying: Common Stock · 1,953 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F6 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 32,317 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002066 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,317 Underlying: Common Stock · 32,317 shares Expires 2033-02-13 F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 4,891 | $162.01 | $792,390.91 |
DisclosureSEC source: 0001225208-23-002066 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,398.8735 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
GrantCommon Stock | 10,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002066 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,289.8735 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 5,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · derivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,338 Underlying: Common Stock · 5,338 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F5 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 88,334 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,334 Underlying: Common Stock · 88,334 shares Expires 2033-02-13 F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 8,578 | $162.01 | $1,389,721.78 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,397.204 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC |
Wolk Joseph JExec VP, CFO
|
GrantCommon Stock | 20,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,975.204 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:34 UTC |
Swanson James D.See Remarks
|
Exercise / conversionRestricted Share Units · Derivative | 1,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001899 · doc4.xml · derivative · entry 5 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,291 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:34 UTC |
Swanson James D.See Remarks
|
Tax withholdingCommon Stock | 388 | $162.08 | $62,887.04 |
DisclosureSEC source: 0001225208-23-001899 · doc4.xml · nonDerivative · entry 2 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,967 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:34 UTC |
Swanson James D.See Remarks
|
Exercise / conversionCommon Stock | 1,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001899 · doc4.xml · nonDerivative · entry 1 Swanson James D. · CIK 0001904785 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 2,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001900 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 761 | $162.08 | $123,342.88 |
DisclosureSEC source: 0001225208-23-001900 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,993.0055 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 2,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001900 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,754.0055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionRestricted Share Units · Derivative | 1,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001901 · doc4.xml · derivative · entry 3 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Tax withholdingCommon Stock | 597 | $162.08 | $96,761.76 |
DisclosureSEC source: 0001225208-23-001901 · doc4.xml · nonDerivative · entry 2 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,662 F2 · balance_after: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionCommon Stock | 1,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001901 · doc4.xml · nonDerivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionRestricted Share Units · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001902 · doc4.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Decker Robert JVP Corporate Controller
|
Tax withholdingCommon Stock | 191 | $162.08 | $30,957.28 |
DisclosureSEC source: 0001225208-23-001902 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,863 F2 · balance_after: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001902 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 1,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001903 · doc4.xml · derivative · entry 3 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,022 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Tax withholdingCommon Stock | 380 | $162.08 | $61,590.40 |
DisclosureSEC source: 0001225208-23-001903 · doc4.xml · nonDerivative · entry 2 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,853 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionCommon Stock | 1,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001903 · doc4.xml · nonDerivative · entry 1 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
Exercise / conversionRestricted Share Units · Derivative | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001904 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
Tax withholdingCommon Stock | 826 | $162.08 | $133,878.08 |
DisclosureSEC source: 0001225208-23-001904 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,635.2661 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Mongon ThibautExec VP, WW Chair, Cons Health
|
Exercise / conversionCommon Stock | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001904 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,461.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionRestricted Share Units · Derivative | 3,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001905 · doc4.xml · derivative · entry 3 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.